Enanta Pharmaceuticals reported $428.22M in Current Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acorda Therapeutics ACOR:US $ 189.72M 31.62M
Amgen AMGN:US $ 21299M 155M
Anika Therapeutics ANIK:US $ 173.47M 3.91M
Arrowhead Research ARWR:US $ 586.76M 263.04M
AstraZeneca AZN:LN 18.74B 809M
Biocryst Pharmaceuticals BCRX:US $ 273.77M 50.03M
Biogen BIIB:US $ 7183.7M 464.2M
Bristol Myers Squibb BMY:US $ 27111M 3081M
Clovis Oncology CLVS:US $ 252.51M 58.32M
Enanta Pharmaceuticals ENTA:US $ 428.22M 17.72M
Gilead Sciences GILD:US $ 13166M 2830M
GlaxoSmithKline GSK:LN 18.52B 1.72B
Halozyme Therapeutics HALO:US $ 941.72M 386.96M
Heron Therapeutics HRTX:US $ 272.29M 41.91M
Insmed INSM:US $ 501M 121.89M
Intercept Pharmaceuticals ICPT:US $ 487.56M 58.18M
Karyopharm Therapeutics KPTI:US $ 255.51M 21.02M
Ligand Pharmaceuticals LGND:US $ 437.43M 63.13M
Marinus Pharmaceuticals MRNS:US $ 123.47M 22.8M
Neurocrine Biosciences NBIX:US $ 1085.4M 69.2M
Novartis NOVN:VX 22.2B 7.48B
Novavax NVAX:US $ 2246.78M 998.58M
Ptc Therapeutics PTCT:US $ 1122.36M 109.38M
Sarepta Therapeutics SRPT:US $ 2271.35M 213.85M
Vertex Pharmaceuticals VRTX:US $ 8200.38M 67M
Vital Therapies VTL:US $ 120.28M 13.46M
YTE INCY:US $ 2359.75M 0.14M